Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 03/17

Trade details

Type: Insider sale
Amount: $711,094.45
Shares · price: 9,229 sh · $77.05 a share
Held after: 59,219 sh
Stock: GeneDx Holdings WGS
Person: Katherine StuelandCEO
Trade date: 26/03/16
Filed: 26/03/17
Days to filing: 1 days

Sold 13.5% of holdings

Share of holding sold: 13.5%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Katherine Stueland's recent trades

Katherine StuelandCEO
Planned saleGeneDx Holdings
Planned sale
GeneDx Holdings
WGS
$1.2M
14,243 sh
$1.2M
Filed 09/01
Traded 09/09
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$360.8K
5,932 sh
$360.8K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$149.4K
2,429 sh
$149.4K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$127.9K
2,140 sh
$127.9K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$195.7K
3,639 sh
$195.7K
Filed 06/11
Traded 06/09

Katherine Stueland, CEO — sold $711.1K of GeneDx Holdings WGS · 13.5% of holdings | Whalegun